Market Research Reports and Industry Reports

Leap Therapeutics Inc (LPTX) - Financial and Strategic SWOT Analysis Review

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Leap Therapeutics Inc (LPTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Leap Therapeutics Inc (Leap Therapeutics) is a clinical-stage biopharmaceutical company that acquires, develops novel therapeutics for cancer research. The companys pipeline encompasses DKN-01, a humanized monoclonal antibody that targets the Dickkopf-1 (DKK-1) protein, and in clinical trials for the treatment of in esophageal cancer, cholangiocarcinoma, a form of bile duct cancer; and non-small cell lung cancer. Its TRX518, is a humanized anti-GITR (glucocorticoid-induced tumor necrosis factor receptor) monoclonal antibody that enhances the immune systems anti-tumor response and is in Phase 1 clinical trials for the treatment of solid tumors. Leap Therapeutics is headquartered in Cambridge, Massachusetts, the US.

Leap Therapeutics Inc Key Recent Developments

Aug 11,2017: Leap Therapeutics Reports Second Quarter 2017 Financial Results
May 12,2017: Leap Therapeutics Reports First Quarter 2017 Financial Results
May 12,2017: Leap Therapeutics Q1 net loss increases
Mar 31,2017: Leap Therapeutics Reports Full Year 2016 Financial Results and Progression-Free Survival Data in Advanced Biliary Tract Cancers

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 - About the Company 5
Leap Therapeutics Inc - Key Facts 5
Leap Therapeutics Inc - Key Employees 6
Leap Therapeutics Inc - Key Employee Biographies 7
Leap Therapeutics Inc - Major Products and Services 8
Leap Therapeutics Inc - History 9
Leap Therapeutics Inc - Locations And Subsidiaries 10
Head Office 10
Other Locations & Subsidiaries 10
Section 2 Company Analysis 11
Leap Therapeutics Inc - Business Description 11
Leap Therapeutics Inc - Corporate Strategy 12
Leap Therapeutics Inc - SWOT Analysis 14
SWOT Analysis - Overview 14
Leap Therapeutics Inc - Strengths 14
Leap Therapeutics Inc - Weaknesses 15
Leap Therapeutics Inc - Opportunities 16
Leap Therapeutics Inc - Threats 17
Leap Therapeutics Inc - Key Competitors 18
Section 3 Company Financial Ratios 19
Financial Ratios - Capital Market Ratios 19
Financial Ratios - Annual Ratios 20
Performance Chart 21
Financial Performance 21
Financial Ratios - Interim Ratios 22
Financial Ratios - Ratio Charts 23
Section 4 Companys Lifesciences Financial Deals and Alliances 24
Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 24
Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 25
Leap Therapeutics Inc, Recent Deals Summary 26
Section 5 Companys Recent Developments 27
Aug 11, 2017: Leap Therapeutics Reports Second Quarter 2017 Financial Results 27
May 12, 2017: Leap Therapeutics Reports First Quarter 2017 Financial Results 28
May 12, 2017: Leap Therapeutics Q1 net loss increases 29
Mar 31, 2017: Leap Therapeutics Reports Full Year 2016 Financial Results and Progression-Free Survival Data in Advanced Biliary Tract Cancers 30
Section 6 Appendix 31
Methodology 31
Ratio Definitions 31
About GlobalData 35
Contact Us 35
Disclaimer 35

List Of Tables


Leap Therapeutics Inc, Key Facts 5
Leap Therapeutics Inc, Key Employees 6
Leap Therapeutics Inc, Key Employee Biographies 7
Leap Therapeutics Inc, Major Products and Services 8
Leap Therapeutics Inc, History 9
Leap Therapeutics Inc, Subsidiaries 10
Leap Therapeutics Inc, Key Competitors 18
Leap Therapeutics Inc, Ratios based on current share price 19
Leap Therapeutics Inc, Annual Ratios 20
Leap Therapeutics Inc, Interim Ratios 22
Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 24
Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 25
Leap Therapeutics Inc, Recent Deals Summary 26
Currency Codes 31
Capital Market Ratios 31
Equity Ratios 32
Profitability Ratios 32
Cost Ratios 33
Liquidity Ratios 33
Leverage Ratios 34
Efficiency Ratios 34

List Of Figures


Leap Therapeutics Inc, Performance Chart (2014 - 2016) 21
Leap Therapeutics Inc, Ratio Charts 23
Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 24
Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 25

Leap Therapeutics Ltd (MCUR) - Financial and Strategic SWOT Analysis Review

This comprehensive SWOT profile of Leap Therapeutics Ltd provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to

USD 300View Report

Shoestring – A Leap of Faith Residential Development – Massachusetts - Project Profile

Synopsis Shoestring A Leap of Faith Residential Development Massachusetts - Project Profile contains information on the scope of the project including project overview and location. The profile also details

USD 75View Report

Echo Therapeutics Inc (ECTE) - Financial and Strategic SWOT Analysis Review

Echo Therapeutics Inc (ECTE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by

USD 125View Report

Cesca Therapeutics Inc (KOOL) - Financial and Strategic SWOT Analysis Review

Cesca Therapeutics Inc (KOOL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by

USD 125View Report

Fill The Form For Sample Request
Name*
Email*
Mobile No.*
LandLine No.
Country Code.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 125
  • Site Licence    USD 250
  • Enterprise Wide Licence    USD 375
$ 125

Reports Details

Published Date : Aug 2017
No. of Pages :35
Country :United States of America
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment
  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube